207 related articles for article (PubMed ID: 11939578)
1. Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N.
Campbell WD; Lazoura E; Okada N; Okada H
Microbiol Immunol; 2002; 46(2):131-4. PubMed ID: 11939578
[TBL] [Abstract][Full Text] [Related]
2. Carboxypeptidase R is an inactivator of complement-derived inflammatory peptides and an inhibitor of fibrinolysis.
Campbell W; Okada N; Okada H
Immunol Rev; 2001 Apr; 180():162-7. PubMed ID: 11414358
[TBL] [Abstract][Full Text] [Related]
3. Carboxypeptidase B2 and N play different roles in regulation of activated complements C3a and C5a in mice.
Morser J; Shao Z; Nishimura T; Zhou Q; Zhao L; Higgins J; Leung LLK
J Thromb Haemost; 2018 May; 16(5):991-1002. PubMed ID: 29383821
[TBL] [Abstract][Full Text] [Related]
4. Carboxypeptidase B2 deficiency reveals opposite effects of complement C3a and C5a in a murine polymicrobial sepsis model.
Shao Z; Nishimura T; Leung LL; Morser J
J Thromb Haemost; 2015 Jun; 13(6):1090-102. PubMed ID: 25851247
[TBL] [Abstract][Full Text] [Related]
5. Pro-carboxypeptidase R is an acute phase protein in the mouse, whereas carboxypeptidase N is not.
Sato T; Miwa T; Akatsu H; Matsukawa N; Obata K; Okada N; Campbell W; Okada H
J Immunol; 2000 Jul; 165(2):1053-8. PubMed ID: 10878383
[TBL] [Abstract][Full Text] [Related]
6. Thrombin activatable fibrinolysis inhibitor (TAFI) - A possible link between coagulation and complement activation in the antiphospholipid syndrome (APS).
Grosso G; Vikerfors A; Woodhams B; Adam M; Bremme K; Holmström M; Ågren A; Eelde A; Bruzelius M; Svenungsson E; Antovic A
Thromb Res; 2017 Oct; 158():168-173. PubMed ID: 28669410
[TBL] [Abstract][Full Text] [Related]
7. Structure-function relationships in thrombin-activatable fibrinolysis inhibitor.
Plug T; Meijers JC
J Thromb Haemost; 2016 Apr; 14(4):633-44. PubMed ID: 26786060
[TBL] [Abstract][Full Text] [Related]
8. Increased Thrombin-Activatable Fibrinolysis Inhibitor in Response to Sublingual Immunotherapy for Allergic Rhinitis.
Yoshida K; Takabayashi T; Imoto Y; Sakashita M; Kato Y; Narita N; Fujieda S
Laryngoscope; 2021 Nov; 131(11):2413-2420. PubMed ID: 33844301
[TBL] [Abstract][Full Text] [Related]
9. Absence of procarboxypeptidase R induces complement-mediated lethal inflammation in lipopolysaccharide-primed mice.
Asai S; Sato T; Tada T; Miyamoto T; Kimbara N; Motoyama N; Okada H; Okada N
J Immunol; 2004 Oct; 173(7):4669-74. PubMed ID: 15383602
[TBL] [Abstract][Full Text] [Related]
10. Regulation of tissue inflammation by thrombin-activatable carboxypeptidase B (or TAFI).
Leung LL; Nishimura T; Myles T
Adv Exp Med Biol; 2008; 632():61-9. PubMed ID: 19025114
[TBL] [Abstract][Full Text] [Related]
11. Targeted disruption of the gene encoding the murine small subunit of carboxypeptidase N (CPN1) causes susceptibility to C5a anaphylatoxin-mediated shock.
Mueller-Ortiz SL; Wang D; Morales JE; Li L; Chang JY; Wetsel RA
J Immunol; 2009 May; 182(10):6533-9. PubMed ID: 19414808
[TBL] [Abstract][Full Text] [Related]
12. Thrombin activatable fibrinolysis inhibitor, a potential regulator of vascular inflammation.
Myles T; Nishimura T; Yun TH; Nagashima M; Morser J; Patterson AJ; Pearl RG; Leung LL
J Biol Chem; 2003 Dec; 278(51):51059-67. PubMed ID: 14525995
[TBL] [Abstract][Full Text] [Related]
13. Regulation of tissue inflammation by thrombin-activatable carboxypeptidase B (or TAFI).
Leung LL; Myles T; Nishimura T; Song JJ; Robinson WH
Mol Immunol; 2008 Oct; 45(16):4080-3. PubMed ID: 18706698
[TBL] [Abstract][Full Text] [Related]
14. Carboxypeptidase B2 and carboxypeptidase N in the crosstalk between coagulation, thrombosis, inflammation, and innate immunity.
Leung LLK; Morser J
J Thromb Haemost; 2018 Jun; ():. PubMed ID: 29883024
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory and anti-fibrinolytic effects of thrombomodulin alfa through carboxypeptidase B2 in the presence of thrombin.
Tawara S; Sakai T; Matsuzaki O
Thromb Res; 2016 Nov; 147():72-79. PubMed ID: 27693845
[TBL] [Abstract][Full Text] [Related]
16. Elastase from activated human neutrophils activates procarboxypeptidase R.
Kawamura T; Okada N; Okada H
Microbiol Immunol; 2002; 46(3):225-30. PubMed ID: 12008933
[TBL] [Abstract][Full Text] [Related]
17. Isolation of three separate anaphylatoxins from complement-activated human serum.
Hugli TE; Gerard C; Kawahara M; Scheetz ME; Barton R; Briggs S; Koppel G; Russell S
Mol Cell Biochem; 1981 Dec; 41():59-66. PubMed ID: 6977086
[TBL] [Abstract][Full Text] [Related]
18. Preferential detection of pro-carboxypeptidase R by enzyme-linked immunosorbent assay.
Tani S; Akatsu H; Ishikawa Y; Okada N; Okada H
Microbiol Immunol; 2003; 47(4):295-300. PubMed ID: 12801067
[TBL] [Abstract][Full Text] [Related]
19. Human C3a and C3a desArg anaphylatoxins have conserved structures, in contrast to C5a and C5a desArg.
Bajic G; Yatime L; Klos A; Andersen GR
Protein Sci; 2013 Feb; 22(2):204-12. PubMed ID: 23184394
[TBL] [Abstract][Full Text] [Related]
20. Molecular cloning and partial characterization of rat procarboxypeptidase R and carboxypeptidase N.
Kato T; Akatsu H; Sato T; Matsuo S; Yamamoto T; Campbell W; Hotta N; Okada N; Okada H
Microbiol Immunol; 2000; 44(8):719-28. PubMed ID: 11021404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
